Research Paper Volume 16, Issue 1 pp 872—910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Figure 6. Mutation feature of XRCC1 in pan-cancer of TCGA. (A) The cBioPortal database was used to analyze the proportion of patients with XRCC1 genomic alterations in pan-cancer. The frequency of mutation type (B) and mutation site (C) of XRCC1 in TCGA tumors was analyzed using the cBioPortal tool. The cBioPortal database was used to explore the impact of XRCC1 mutation status on OS (D), DFS (E), PFS (F), and DSS (G) of cancer patients.